Health Care & Life Sciences » Biotechnology | EPIRUS Biopharmaceuticals Inc.

EPIRUS Biopharmaceuticals Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2011
2012
2013
2014
2015
Net Income before Extraordinaries
42,043.00
44,327.00
38,617.00
41,844.00
52,188.00
Depreciation, Depletion & Amortization
7,205.00
5,373.00
10,048.00
165.00
597.00
Other Funds
1,916.00
1,658.00
3,966.00
4,304.00
4,040.00
Funds from Operations
32,922.00
37,296.00
24,603.00
37,375.00
48,159.00
Changes in Working Capital
454.00
1,193.00
5,132.00
1,855.00
1,676.00
Net Operating Cash Flow
33,376.00
38,489.00
29,735.00
35,520.00
46,483.00
Capital Expenditures
350.00
48.00
180.00
1,467.00
477.00
Sale of Fixed Assets & Businesses
43.00
308.00
7.00
13,760.00
889.00
Purchase/Sale of Investments
3,313.00
15,065.00
30,059.00
-
-
Net Investing Cash Flow
3,620.00
15,325.00
29,886.00
12,293.00
841.00
Issuance/Reduction of Debt, Net
16,615.00
4,293.00
6,496.00
12,236.00
7,500.00
Net Financing Cash Flow
36,938.00
24,943.00
13,286.00
42,841.00
55,817.00
Net Change in Cash
70.00
1,781.00
13,427.00
19,614.00
10,152.00
Free Cash Flow
33,726.00
38,537.00
29,915.00
35,737.00
46,960.00
Deferred Taxes & Investment Tax Credit
-
-
-
-
608.00
Other Sources
-
-
-
-
3,829.00
Change in Capital Stock
20,323.00
29,236.00
19,782.00
30,605.00
48,317.00
Exchange Rate Effect
12.00
2.00
10.00
-
23.00
Other Uses
-
-
-
-
3,400.00

About EPIRUS Biopharmaceuticals

View Profile
Address
699 Boylston Street
Boston Massachusetts 02116
United States
Employees -
Website http://www.epirusbiopharma.com
Updated 07/08/2019
EPIRUS Biopharmaceuticals, Inc. is a biopharmaceutical company focused on building a pure-play, sustainable and profitable biosimilar business. It focuses on biosimilars, which are biologic drugs that are demonstrated to be highly similar to a previously approved biologic drug, known as a reference product. The company was founded on November 26, 2008 and is headquartered in Boston, MA.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.